Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain
Kapil Gadkar(Sea Turtle Conservancy), Saroja Ramanujan(Unknown), Sean B. Joseph, Joy Yu Zuchero, Jitendra Kanodia, Jessica A. Couch(Sunesis (United States)), Daniela Bumbaca Yadav, Jasvinder K. Atwal, Ryan J. Watts(Denali Therapeutics (United States)), Mark S. Dennis(Denali Therapeutics (United States)), Margaret Kenrick(Snap (United States)), Saileta Prabhu
Cited by 56
Related Papers
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
|Nature Biotechnology|2012|997
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
|Journal of Biological Chemistry|2002|496
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
|Science Translational Medicine|2014|373